(Q34568144)

3 August 2017

1 reference

title

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. (English)

1 reference

3 August 2017

1 reference

1 reference

Gupta RA

1

1 reference

3 August 2017

Dubois RN

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

3 August 2017

published in

Nature Reviews Cancer

1 reference

3 August 2017

volume

1

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

11-21

1 reference

3 August 2017

cites work

Cancer statistics, 2000.

1 reference

7 January 2021

Prostaglandin synthase 2.

1 reference

7 January 2021

Inflammation, reproduction, cancer and all that.... The regulation and role of the inducible prostaglandin synthase

1 reference

7 January 2021

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

7 January 2021

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

7 January 2021

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

1 reference

7 January 2021

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

1 reference

7 January 2021

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

1 reference

7 January 2021

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

7 January 2021

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

7 January 2021

Sulindac for polyposis of the colon

1 reference

7 January 2021

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

7 January 2021

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention

1 reference

7 January 2021

Identification of a Gene Located at Chromosome 5q21 that Is Mutated in Colorectal Cancers

1 reference

7 January 2021

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

1 reference

7 January 2021

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

1 reference

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

7 January 2021

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

1 reference

7 January 2021

Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin

1 reference

7 January 2021

The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)

1 reference

7 January 2021

Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway.

1 reference

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

7 January 2021

Sulindac inhibits activation of the NF-kappaB pathway

1 reference

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

7 January 2021

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

1 reference

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

7 January 2021

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

1 reference

7 January 2021

Role of BAX in the apoptotic response to anticancer agents

1 reference

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

7 January 2021

Elevated cyclooxygenase-2 levels in Min mouse adenomas

1 reference

7 January 2021

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

7 January 2021

Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors

1 reference

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

7 January 2021

Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms

1 reference

7 January 2021

Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.

1 reference

7 January 2021

Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice

1 reference

7 January 2021

Localization of cyclooxygenase-2 in human sporadic colorectal adenomas

1 reference

7 January 2021

High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.

1 reference

7 January 2021

ONCOGENESIS: Landscaping the Cancer Terrain

1 reference

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

7 January 2021

Significant Roles of Inducible Cyclooxygenase (COX)-2 in Angiogenesis in Rat Sponge Implants

1 reference

7 January 2021

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

1 reference

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

7 January 2021

Distribution and function of prostanoid receptors: studies from knockout mice

1 reference

7 January 2021

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

1 reference

7 January 2021

Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer

1 reference

7 January 2021

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

7 January 2021

Nuclear localization of prostaglandin E2 receptors

1 reference

7 January 2021

Hereditary mixed polyposis syndrome: a zebra or a horse dressed in pinstripes

1 reference

7 January 2021

Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice

1 reference

7 January 2021

Inducible cyclooxygenase may have anti-inflammatory properties

1 reference

7 January 2021

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

1 reference

7 January 2021

Prospective study of regular aspirin use and the risk of breast cancer

1 reference

7 January 2021

Non-steroidal anti-inflammatory drugs and prostate cancer progression

1 reference

7 January 2021

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

1 reference

7 January 2021

Over-the-counter analgesics and risk of ovarian cancer

1 reference

7 January 2021

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

1 reference

7 January 2021

Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer

1 reference

7 January 2021

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

7 January 2021

The expression of p185(HER-2/neu) correlates with the stage of disease and survival in colorectal cancer

1 reference

7 January 2021

Growth stimulation by coexpression of transforming growth factor-alpha and epidermal growth factor-receptor in normal and adenomatous human colon epithelium

1 reference

7 January 2021

Combinatorial chemoprevention of intestinal neoplasia

1 reference

7 January 2021

Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth

1 reference

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

7 January 2021

Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers

1 reference

7 January 2021

Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen

1 reference

7 January 2021

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

1 reference

7 January 2021

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

1 reference

7 January 2021

Familial adenomatous polyposis

1 reference

7 January 2021

Identification and characterization of the familial adenomatous polyposis coli gene

1 reference

7 January 2021

Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas

1 reference

7 January 2021

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

1 reference

7 January 2021

Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene

1 reference

7 January 2021

Intestinal cancer induced by N-nitroso compounds

1 reference

7 January 2021

Sulindac suppresses tumorigenesis in the Min mouse.

1 reference

7 January 2021

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

7 January 2021

Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane

1 reference

7 January 2021

Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice.

1 reference

7 January 2021

Meloxicam inhibits the growth of colorectal cancer cells

1 reference

7 January 2021

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

1 reference

7 January 2021

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/35094017

1 reference

Dimensions Publication ID

3 August 2017

1002632915

0 references

1 reference